Ads
related to: biotech stocks with phase 3 trials
Search results
Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
InvestorPlace· 4 hours agoThanks to biotech companies that produce transformative drugs and treatments, we now have the collective ability to combat diseases that used to bring...
3 MidCap Biotech Stocks Going in Varied Directions
TheStreet.com· 1 day agoInstead of those worthy topics, however, today I thought I would focus on some of my recent covered call trades on biotech names, in order to incorporate...
2 Biotech Stocks to Buy in May | The Motley Fool
The Motley Fool· 5 days agoThe stock market has performed relatively well since the beginning of the year although, of course, there is no guarantee that it will maintain that...
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
InvestorPlace· 2 days agoBiotech stocks are not for the faint of heart. Between juggling FDA approvals, new product pipelines...
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
InvestorPlace· 5 days agoAs we delve deeper into 2024, biotech stocks are commanding the attention of growth-focused...
7 Biotech Stocks to Put on Your Breakthrough Radar
InvestorPlace· 3 days agoFor those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower. ...
1 Stock That More Than Doubled This Year That I Wouldn't Touch With a 10-Foot Pole
Motley Fool via Yahoo Finance· 6 days agostock offering, which would likely drag down its shares. Or maybe Ocugen will issue debt. That said,...
Insmed shares rise on positive phase 3 trial results By Investing.com
Investing.com· 2 days agoThe successful trial outcomes are seen as a significant milestone that could transform Insmed into a...
2 Potentially High-Reward Growth Stocks to Buy Right Now
Motley Fool via Yahoo Finance· 1 day agoIf this trial is successful, it will validate Avidity's novel...significantly impact shares to the...
5 stocks that are back from the dead
Financial Post via Yahoo Finance· 13 hours agoViking has a promising subcutaneously administered obesity drug in Phase II trials that has shown solid clinical results. It has US...continue...
